{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-21-000296","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.440575+00:00","generated_at":"2026-06-29T22:22:42.374848+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Globus Medical Q2 revenue $251M (+68.6% YoY); raises FY2021 guidance to $950M sales, $1.89-2.00 EPS","bullets":["Q2 worldwide net sales of $251.0M, up 68.6% YoY; GAAP net income $41.5M (16.6% of sales), up 299.4% YoY.","GAAP diluted EPS $0.40, Non-GAAP diluted EPS $0.56, compared to ($0.21) and $0.07 in Q2 2020 respectively.","U.S. Spine business grew ~64% YoY; Enabling Technologies revenue $21M (nearly 4x Q2 2020).","Raised FY2021 guidance: net sales to $950M (from $925M) and non-GAAP diluted EPS to $1.89-$2.00.","Cash and marketable securities $914.2M, no debt; generated $59.2M operating cash flow, $50.8M free cash flow in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-21-000296","json":"https://secwatch.observer/filing/0001562762-21-000296.json","markdown":"https://secwatch.observer/filing/0001562762-21-000296.md","text":"https://secwatch.observer/filing/0001562762-21-000296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000156276221000296/0001562762-21-000296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000156276221000296/gmed-20210804x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:22:42.374848+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}